Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Vineet Laboratories manufactures organic intermediates, fine chemicals, organometallics and custom synthesis used as pharmaceutical ingredients.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Vineet Laboratories Limited has informed the Exchange regarding 'Disclosure Under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. '. | Download
Vineet Laboratories Limited has informed the Exchange regarding 'Disclosure Under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. '. | Download
We are hereby submitting the Newspaper Advertisement in Financial Express (English Language) and Nava Express ( Telangana Language) regarding the Unaudited Standalone Financial Statement for the second quarter and half year ended on September 30,2024 | Download
We are hereby submitting the Newspaper Advertisement in Financial Express (English Language) and Nava Express ( Telangana Language) regarding the Unaudited Standalone Financial Statement for the second quarter and half year ended on September 30,2024 | Download
Final • Div/Share: ₹ 1
Decreased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 1.43%